Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: The coronary artery risk development in young adults study

Atherosclerosis

Volumn 235, Issue 2, 2014, Pages 599-605

  VanWagner, Lisa B ^a   Ning, Hongyan ^a   Lewis, Cora E ^b   Shay, Christina M ^c   Wilkins, John ^a   Carr, J Jeffrey ^d   Terry, James G ^e   Lloyd Jones, Donald M ^a   Jacobs, David R ^f   Carnethon, Mercedes R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e WAKE FOREST UNIVERSITY   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Calcium; Cardiovascular diseases; Epidemiology; Imaging; Liver; Obesity; Risk factors

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CONTRAST MEDIUM; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGATSTON SCORE; ARTICLE; CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HEALTH BEHAVIOR; HUMAN; HYPERTENSION; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; ABDOMINAL AORTA; AORTA DISEASE; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CLINICAL TRIAL; COMPLICATION; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; MULTICENTER STUDY; RADIOGRAPHY; YOUNG ADULT;

ADULT; AORTA, ABDOMINAL; AORTIC DISEASES; ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY VESSELS; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR CALCIFICATION; YOUNG ADULT;

EID: 84907380058     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.05.962     Document Type: Article

References (45)

1. Vernon G., Baranova A., Younossi Z.M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 2011, 34:274-285.
2. Charlton M. Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol 2004, 2:1048-1058.
3. Lazo M., Hernaez R., Bonekamp S., Kamel I.R., Brancati F.L., Guallar E., Clark J.M. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011, 343. d6891.
4. Nestel P.J., Mensink R.P. Perspective: nonalcoholic fatty liver disease and cardiovascular risk. Curr Opin Lipidol 2013, 24:1-3.
5. Bhatia L.S., Curzen N.P., Calder P.C., Byrne C.D. Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?. Eur Heart J 2012, 33:1190-1200.
6. Targher G., Day C.P., Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010, 363:1341-1350.
7. Pacana T., Fuchs M. The cardiovascular link to nonalcoholic fatty liver disease: a critical analysis. Clin Liver Dis 2012, 16:599-613.
8. Lu H., Liu H., Hu F., Zou L., Luo S., Sun L. Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis. International journal of endocrinology 2013, 2013:124958.
9. Villanova N., Moscatiello S., Ramilli S., Bugianesi E., Magalotti D., Vanni E., Zoli M., Marchesini G. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005, 42:473-480.
10. Akabame S., Hamaguchi M., Tomiyasu K., Tanaka M., Kobayashi-Takenaka Y., Nakano K., Oda Y., Yoshikawa T. Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT). Circ J 2008, 72:618-625.
11. Assy N., Djibre A., Farah R., Grosovski M., Marmor A. Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology 2010, 254:393-400.
12. Volzke H., Robinson D.M., Kleine V., Deutscher R., Hoffmann W., Ludemann J., Schminke U., Kessler C., John U. Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 2005, 11:1848-1853.
13. Park B.J., Kim Y.J., Kim D.H., Kim W., Jung Y.J., Yoon J.H., Kim C.Y., Cho Y.M., Kim S.H., Lee K.B., Jang J.J., Lee H.S. Visceral adipose tissue area is an independent risk factor for hepatic steatosis. J Gastroenterol Hepatol 2008, 23:900-907.
14. Kim D., Choi S.Y., Park E.H., Lee W., Kang J.H., Kim W., Kim Y.J., Yoon J.H., Jeong S.H., Lee D.H., Lee H.S., Larson J., Therneau T.M., Kim W.R. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 2012, 56:605-613.
15. Chen C.H., Nien C.K., Yang C.C., Yeh Y.H. Association between nonalcoholic fatty liver disease and coronary artery calcification. Dig Dis Sci. 2010, 55:1752-1760.
16. Sung K.C., Wild S.H., Kwag H.J., Byrne C.D. Fatty Liver, Insulin Resistance, and Features of Metabolic Syndrome: Relationships with coronary artery calcium in 10,153 people. Diabetes Care 2012, 35(11):2359-2364.
17. Liu J., Musani S.K., Bidulescu A., Carr J.J., Wilson J.G., Taylor H.A., Fox C.S. Fatty liver, abdominal adipose tissue and atherosclerotic calcification in African Americans: the Jackson Heart Study. Atherosclerosis 2012, 224:521-525.
18. Ding J., Kritchevsky S.B., Hsu F.C., Harris T.B., Burke G.L., Detrano R.C., Szklo M., Criqui M.H., Allison M., Ouyang P., Brown E.R., Carr J.J. Association between non-subcutaneous adiposity and calcified coronary plaque: a substudy of the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr 2008, 88:645-650.
19. Friedman G.D., Cutter G.R., Donahue R.P., Hughes G.H., Hulley S.B., Jacobs D.R., Liu K., Savage P.J. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988, 41:1105-1116.
20. Chalasani N., Younossi Z., Lavine J.E., Diehl A.M., Brunt E.M., Cusi K., Charlton M., Sanyal A.J. The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012, 55:2005-2023.
21. Warnick G.R. Enzymatic methods for quantification of lipoprotein lipids. Methods Enzymol 1986, 129:101-123.
22. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
23. Grundy S.M., Brewer H.B., Cleeman J.I., Smith S.C., Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004, 24:e13-e18.
24. Davidson L.E., Kuk J.L., Church T.S., Ross R. Protocol for measurement of liver fat by computed tomography. J Appl Physiol 2006, 100:864-868.
25. Kodama Y., Ng C.S., Wu T.T., Ayers G.D., Curley S.A., Abdalla E.K., Vauthey J.N., Charnsangavej C. Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol 2007, 188:1307-1312.
26. Zeb I., Li D., Nasir K., Katz R., Larijani V.N., Budoff M.J. Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis. Acad Radiol 2012, 19:811-818.
27. Park S.H., Kim P.N., Kim K.W., Lee S.W., Yoon S.E., Park S.W., Ha H.K., Lee M.G., Hwang S., Lee S.G., Yu E.S., Cho E.Y. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 2006, 239:105-112.
28. Boyce C.J., Pickhardt P.J., Kim D.H., Taylor A.J., Winter T.C., Bruce R.J., Lindstrom M.J., Hinshaw J.L. Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 2010, 194:623-628.
29. Agatston A.S., Janowitz W.R., Hildner F.J., Zusmer N.R., Viamonte M., Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990, 15:827-832.
30. Carr J.J., Crouse J.R., Goff D.C., D'Agostino R.B., Peterson N.P., Burke G.L. Evaluation of subsecond gated helical CT for quantification of coronary artery calcium and comparison with electron beam CT. AJR Am J Roentgenol 2000, 174:915-921.
31. Detrano R.C., Anderson M., Nelson J., Wong N.D., Carr J.J., McNitt-Gray M., Bild D.E. Coronary calcium measurements: effect of CT scanner type and calcium measure on rescan reproducibility-MESA study. Radiology 2005, 236:477-484.
32. Chung H., McClelland R.L., Katz R., Carr J.J., Budoff M.J. Repeatability limits for measurement of coronary artery calcified plaque with cardiac CT in the Multi-Ethnic Study of Atherosclerosis. AJR Am J Roentgenol 2008, 190:W87-W92.
33. Budoff M.J., McClelland R.L., Chung H., Wong N.D., Carr J.J., McNitt-Gray M., Blumenthal R.S., Detrano R.C. Reproducibility of coronary artery calcified plaque with cardiac 64-MDCT: the Multi-Ethnic Study of Atherosclerosis. AJR Am J Roentgenol 2009, 192:613-617.
34. Liu J., Fox C.S., Hickson D., Bidulescu A., Carr J.J., Taylor H.A. Fatty liver, abdominal visceral fat, and cardiometabolic risk factors: the Jackson Heart Study. Arterioscler Thromb Vasc Biol 2011, 31:2715-2722.
35. Chhabra R., O'Keefe J.H., Patil H., O'Keefe E., Thompson R.C., Ansari S., Kennedy K.F., Lee L.W., Helzberg J.H. Association of coronary artery calcification with hepatic steatosis in asymptomatic individuals. Mayo Clin Proc 2013, 88:1259-1265.
36. Tabibian J.H., Lazo M., Durazo F.A., Yeh H.C., Tong M.J., Clark J.M. Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population?. J Gastroenterol Hepatol 2011, 26:501-509.
37. Weston S.R., Leyden W., Murphy R., Bass N.M., Bell B.P., Manos M.M., Terrault N.A. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 2005, 41:372-379.
38. Browning J.D., Szczepaniak L.S., Dobbins R., Nuremberg P., Horton J.D., Cohen J.C., Grundy S.M., Hobbs H.H. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
39. Yu S.S., Castillo D.C., Courville A.B., Sumner A.E. The triglyceride paradox in people of African descent. Metab Syndr Relat Disord 2012, 10:77-82.
40. Chow C.C., Periwal V., Csako G., Ricks M., Courville A.B., Miller B.V., Vega G.L., Sumner A.E. Higher acute insulin response to glucose may determine greater free fatty acid clearance in African-American women. J Clin Endocrinol Metab 2011, 96:2456-2463.
41. Palmer N.D., Musani S.K., Yerges-Armstrong L.M., Feitosa M.F., Bielak L.F., Hernaez R., Kahali B., Carr J.J., Harris T.B., Jhun M.A., Kardia S.L., Langefeld C.D., Mosley T.H., Norris J.M., Smith A.V., Taylor H.A., Wagenknecht L.E., Liu J., Borecki I.B., Peyser P.A., Speliotes E.K. Characterization of European-ancestry NAFLD-associated Variants in individuals of African and Hispanic descent. Hepatology 2013, 58(3):966-975.
42. Musso G., Gambino R., Cassader M., Pagano G. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Ann Med 2011, 43:617-649.
43. Speliotes E.K., Massaro J.M., Hoffmann U., Vasan R.S., Meigs J.B., Sahani D.V., Hirschhorn J.N., O'Donnell C.J., Fox C.S. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010, 51:1979-1987.
44. DeFilippis A.P., Blaha M.J., Martin S.S., Reed R.M., Jones S.R., Nasir K., Blumenthal R.S., Budoff M.J. Nonalcoholic fatty liver disease and serum lipoproteins: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2013, 227:429-436.
45. Mofrad P., Contos M.J., Haque M., Sargeant C., Fisher R.A., Luketic V.A., Sterling R.K., Shiffman M.L., Stravitz R.T., Sanyal A.J. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003, 37:1286-1292.